Evidence map›Paper›PMID 40711465›Full record

ReviewAntimicrobial agents and chemotherapy2025

Santiago Castillo-Ramírez, Alejandro Aguilar-Vera, Ayush Kumar, Benjamin Evans

Abstract readReview
In one paragraph

Review in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Convergent Architecture of thePathogens (Basel, Switzerland) · 2026
    Article
  4. The population structure ofApplied and environmental microbiology · 2026
    Article
  5. Article
  6. Convergent evolution of ST2 and ST164 mediates dissemination of the blaAnnals of clinical microbiology and antimicrobials · 2026
    Article
  7. Article
  8. Comparative genomic analysis ofJAC-antimicrobial resistance · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. mSphere · 2026
    Article
  14. DiverseMicrobiology spectrum · 2026
    Article
  15. Review
  16. mSphere · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Santiago Castillo-RamírezPrograma de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.ORCID 0000-0003-3922-7088
Alejandro Aguilar-VeraPrograma de Genómica Evolutiva, Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Mexico.
Ayush Kumar *Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0001-6395-7932
Benjamin Evans *Centre for Metabolic Health, Norwich Medical School, University of East Anglia, Norwich, United Kingdom.

Funding

Discovery Grant NSERC Canada RGPIN-2021-02902PAPIIT-UNAM IN209524
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnimalsAnti-Bacterial AgentsCross InfectionDrug Resistance, Multiple, BacterialHumansMolecular EpidemiologyPetsZoonosesAnti-Bacterial AgentsAcinetobacter baumanniiantimicrobial resistanceenvironmentgenomic epidemiologyinternational clonesnon-human populationsOne Health

Identifiers

PMID40711465
PMCPMC12406671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.